2010
LONG TERM RESULTS FOR THE DIVERGE TRIAL: 1 AND 2 YEAR CLINICAL OUTCOMES FOR THE AXXESS BIOLIUMS A9 ELUTING SELF EXPANDING STENT FOR THE TREATMENT OF DE NOVO BIFURCATION LESIONS
Lansky A, Verheye S, Ormiston J, Dubois C, Cristea E, Mehran R, Trauthen B, Johnson R. LONG TERM RESULTS FOR THE DIVERGE TRIAL: 1 AND 2 YEAR CLINICAL OUTCOMES FOR THE AXXESS BIOLIUMS A9 ELUTING SELF EXPANDING STENT FOR THE TREATMENT OF DE NOVO BIFURCATION LESIONS. Journal Of The American College Of Cardiology 2010, 55: a199.e1870. DOI: 10.1016/s0735-1097(10)61871-2.Peer-Reviewed Original Research
2009
9-Month Clinical, Angiographic, and Intravascular Ultrasound Results of a Prospective Evaluation of the Axxess Self-Expanding Biolimus A9-Eluting Stent in Coronary Bifurcation Lesions The DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) Study
Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, Trauthen B, Hasegawa T, Koo BK, Fitzgerald PJ, Mehran R, Lansky AJ. 9-Month Clinical, Angiographic, and Intravascular Ultrasound Results of a Prospective Evaluation of the Axxess Self-Expanding Biolimus A9-Eluting Stent in Coronary Bifurcation Lesions The DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) Study. Journal Of The American College Of Cardiology 2009, 53: 1031-1039. PMID: 19298915, DOI: 10.1016/j.jacc.2008.12.012.Peer-Reviewed Original ResearchConceptsPercent neointimal volume obstructionMajor adverse cardiac eventsNeointimal volume obstructionCoronary bifurcation lesionsBifurcation lesionsAXXESS stentVolume obstructionMulticenter studyMyocardial infarctionLate lossParent vesselDe novo bifurcation lesionsEnd pointIntravascular ultrasound resultsNovo bifurcation lesionsAdverse cardiac eventsComposite of deathPrimary end pointSecondary end pointsProspective multicenter studySirolimus-eluting stentsAdverse late outcomesSide branchesDrug-eluting stentsLate stent thrombosis